| Reporting year |
2021 |
| Provider country/institution - code |
301 |
| Provider country/institution - name |
Canada |
| Provider agency |
Miscellaneous |
| Provider project number |
175527-1 |
| TOSSD ID Number |
20218023790001 |
| TOSSD recipient - code |
998 |
| TOSSD recipient - name |
Developing countries, unspecified |
| Region |
Developing countries, unspecified |
| Project title |
COVID-19 Variant Supplement - Development of a nanoparticle-based vaccine candidate to the SARS-CoV-2 |
| Description |
COVID-19 Variant Supplement - Development of a nanoparticle-based vaccine candidate to the SARS-CoV-2 |
| External link |
|
| SDG focus |
3 |
| SDG goal level explanation |
Canada is firmly committed to the 2030 Agenda for Sustainable Development, but it is not yet possible to report systematically at the transactional level. Canada is reviewing its processes and data systems to adopt a new set of tools to eventually integrate reporting at the target level. In the meantime Canada will continue to report at the goal level. |
| Keywords |
#COVID-19 |
| Sector category - code |
120 |
| Sector category - name |
Health |
| Purpose code |
12182 |
| Purpose name |
Medical research |
| ISICcode |
7210 |
| ISIC name |
Research and experimental development on natural sciences and engineering |
| ISIC lvl |
M |
| ISIC description letter lvl |
Professional, scientific and technical activities |
| Channel category - code |
51000 |
| Channel category - name |
|
| Other Partners |
|
| Channel - code |
51000 |
| Channel - name |
University, college or other teaching institution, research institute or think-tank |
| Channel |
Université Laval |
| Modality - code |
D02 |
| Modality - name |
Other technical co-operation |
| Financial instrument - code |
2100 |
| Financial instrument - name |
Direct provider spending |
| Financing arrangement - code |
|
| Financing arrangement - name |
|
| Framework of collaboration - code |
|
| Framework of collaboration - name |
|
| TOSSD pillar |
2 |
| TOSSD sub-pillar |
2 |
| Amount committed (USD thousand) |
39.88831272437176 |
| Deflated Amount committed (USD thousand) |
41.16145207851192 |
| Amount disbursed (USD thousand) |
39.88831272437176 |
| Deflated amount disbursed (USD thousand) |
41.16145207851192 |
| Reflows to the provider (USD thousand) |
0 |
| Deflated reflows to the provider (USD thousand) |
0 |
| Amount mobilised (USD thousand) |
|
| Deflated amount mobilised (USD thousand) |
|
| Salary cost (PPPs) |
|
| Concessionality |
1 |
| Maturity (in months) |
|
| Leveraging mechanism |
|
| Origin of the funds mobilised |
|
| Source name |
TOSSD |